financetom
Business
financetom
/
Business
/
Metal Sky Star Acquisition to Buy Fedilco Group
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Metal Sky Star Acquisition to Buy Fedilco Group
Oct 17, 2024 12:48 PM

10:13 AM EDT, 10/15/2024 (MT Newswires) -- Metal Sky Star Acquisition ( MSSA ) said Tuesday it has signed a letter of intent to acquire Fedilco Group, which holds an 80% equity stake in Armenia-based telecommunications company Viva Armenia.

Metal Sky Star Acquisition ( MSSA ) will purchase all outstanding shares of Fedilco Group following necessary approvals from Armenian state authorities, the company said.

Financial details of the agreement were not disclosed.

Price: 11.58, Change: +0.20, Percent Change: +1.76

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Insider Sold Shares Worth $632,759, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $632,759, According to a Recent SEC Filing
Aug 20, 2025
05:33 PM EDT, 08/19/2025 (MT Newswires) -- Tolga Tanguler, Executive Vice President, Chief Commercial Officer, on August 15, 2025, sold 1,396 shares in Alnylam Pharmaceuticals ( ALNY ) for $632,759. Following the Form 4 filing with the SEC, Tanguler has control over a total of 29,466 common shares of the company, with 29,466 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1178670/000173527625000091/xslF345X05/edgardoc.xml ...
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,030,727, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,030,727, According to a Recent SEC Filing
Aug 20, 2025
05:34 PM EDT, 08/19/2025 (MT Newswires) -- Jeffrey V. Poulton, Executive Vice President, Chief Financial Officer, on August 15, 2025, sold 2,274 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,030,727. Following the Form 4 filing with the SEC, Poulton has control over a total of 50,178 common shares of the company, with 50,121 shares held directly and 57 controlled...
Alnylam Pharmaceuticals Insider Sold Shares Worth $3,163,346, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $3,163,346, According to a Recent SEC Filing
Aug 20, 2025
05:34 PM EDT, 08/19/2025 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on August 15, 2025, sold 6,979 shares in Alnylam Pharmaceuticals ( ALNY ) for $3,163,346. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 56,628 common shares of the company, with 56,221 shares held directly and 407 controlled indirectly. SEC Filing:...
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,299,746, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,299,746, According to a Recent SEC Filing
Aug 20, 2025
05:33 PM EDT, 08/19/2025 (MT Newswires) -- Pushkal Garg, Executive Vice President, Chief of R&D, on August 15, 2025, sold 2,851 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,299,746. Following the Form 4 filing with the SEC, Garg has control over a total of 20,902 common shares of the company, with 20,221 shares held directly and 681 controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved